Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis

S Inamdar, D Han, M Passi, DV Sejpal… - Gastrointestinal …, 2017 - Elsevier
Background and Aims Rectal indomethacin is a popular chemopreventive agent to help
prevent post-ERCP pancreatitis (PEP). Previous meta-analyses have shown an overall …
被引用次数：73 相关文章

Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis

S Inamdar, D Han, M Passi, DV Sejpal… - Gastrointestinal …, 2017 - infona.pl
Rectal indomethacin is a popular chemopreventive agent to help prevent post-ERCP
pancreatitis (PEP). Previous meta-analyses have shown an overall protective effect for PEP …

Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis

S Inamdar, D Han, M Passi, DV Sejpal… - Gastrointestinal …, 2017 - giejournal.org
Background and Aims Rectal indomethacin is a popular chemopreventive agent to help
prevent post-ERCP pancreatitis (PEP). Previous meta-analyses have shown an overall …

Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis.

S Inamdar, D Han, M Passi, DV Sejpal… - Gastrointestinal …, 2016 - europepmc.org
Methods A comprehensive search of multiple literature databases in April 2016 was
performed. Human prospective randomized controlled trials with placebo controls that …

Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis

S Inamdar, D Han, M Passi… - Gastrointestinal …, 2017 - pubmed.ncbi.nlm.nih.gov
Background and aims Rectal indomethacin is a popular chemopreventive agent to help
prevent post-ERCP pancreatitis (PEP). Previous meta-analyses have shown an overall …